DFX Intelligence

Data Factory

VentureFirminstitutional vcexempt_reporting_adviser

KDT Ventures

Venture Capital

KdT Ventures is the standard for early-stage frontier science investing. Chemistry and biology are the software of our physical world; science is the source code of reality, from atoms to algorithms.

This is the graph view. The full profile, with its team, deals and sources, is on Venture Capital.Open the full profile →

Search this name across graphsid dfx:vc:2e1b1770-57ac-422c-85fd-48330ffc6d65

Data as of Sep 17, 2026 (this record's last observation) from federal regulator filings, firm and issuer disclosures. Page built Sep 19, 2026, 1:44 PM UTC and rebuilt at most every 15 minutes.

Relationships: 40
Dated events: 4
On other graphs: 1
Observed: Sep 12, 2026 to Sep 17, 2026
38 observations

Across DFX

same identity by shared identifier, citation, or a bridge measured by hand

RIA / Wealth Managementidentity

KDT VENTURES

Registered adviser · shared crd

Facts

fact = as filed or announced; derived = computed by DFX; estimate = a band, never a point

Funds: 4
Vintages: 2017 to 2017
Reported GAV: $202Mgross asset value on Form ADV; never dry powder
Funds with fundraising evidence: 0derived
Investments: 26
Portfolio companies: 24
Investments, 12m: 26
Partner-attributed: 0
People: 10
Investment professionals: 7derived
Co-investors: 0derived
LP relationships: 0
Stated stages: pre_seed,seed,series_a,early
Latest Form D: Jun 6, 2024
Latest ADV filing: Mar 25, 2026
Website: kdtvc.com

Funds

Fund	Vintage	Lifecycle	Form D sold	GAV
KDT Ventures Fund I, LP	2017	Harvest	$3.5M	$65.0M
KDT Ventures Fund III, LP	n/a	Unknown	$0	$80.0M
KdT Ventures Fund IV, LP	n/a	Unknown	$0	n/a
KDT Ventures Fund II, LP	n/a	Unknown	$0	$57.0M

Investments

round size is never this investor's check

Company	State	Stage	Round size	Partner	Attribution	Observed
Andes	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Aperiambio	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Azitra	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Bullseyebiosciences	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Cirsiumbio	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Creasallis	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Macrocycle	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Checkerspot, Inc.	CA	n/a	n/a	n/a	Unknown	Sep 16, 2026
Epana Bio	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Exthymic Corp	CA	n/a	n/a	n/a	Unknown	Sep 16, 2026
General Sense	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Indexbiosystems	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Leeta	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Molecule	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Neptune	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Perceptive	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Phnxmaterials	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Radartx	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Revel	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Skeletalis	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Solugen	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
STRM.BIO Therapeutics S e e d	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Zagbio	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Zymochem	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Checkerspot, Inc.	CA	n/a	n/a	n/a	Unknown	Sep 12, 2026

Co-investors

pairs come only from shared rounds and listings

Investor	Co-investor	Shared deals	Shared companies	Last observed	Strength
KDT Ventures	Breakout Management, LLC	3	3	Sep 16, 2026	Recurring
KDT Ventures	Pillar Companies Management, LLC	1	1	Sep 16, 2026	One time
KDT Ventures	Compound Advisors, LLC	1	1	Sep 16, 2026	One time
KDT Ventures	Voyager Partners Management LLC	1	1	Sep 16, 2026	One time
KDT Ventures	Aera Funds Management Pte. Ltd.	1	1	Sep 16, 2026	One time
KDT Ventures	Civilization Ventures Management, LLC	1	1	Sep 16, 2026	One time
Rule 1 Management LLC	KDT Ventures	1	1	Sep 16, 2026	One time
Hummingbird Ventures V US GP LLC	KDT Ventures	1	1	Sep 16, 2026	One time
KDT Ventures	Next Legacy Management, LLC	1	1	Sep 16, 2026	One time
KDT Ventures	Shine Capital	1	1	Sep 16, 2026	One time
KDT Ventures	Delos Advisors, Inc.	1	1	Sep 16, 2026	One time
KDT Ventures	Clean Energy Venture Management, LLC	1	1	Sep 16, 2026	One time

Relationships

Invested in (24)

→ STRM.BIO Therapeutics S e e dCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ ZymochemCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ MacrocycleCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ MoleculeCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ NeptuneCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ PerceptiveCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ PhnxmaterialsCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ RadartxCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ RevelCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ SkeletalisCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ SolugenCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ ZagbioCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ AndesCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ AperiambioCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ AzitraCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ BullseyebiosciencesCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Checkerspot, Inc.CompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ CirsiumbioCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ CreasallisCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Epana BioCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Exthymic CorpCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ General SenseCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ IndexbiosystemsCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ LeetaCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site

Employs (9)

→ Kaitlyn DavisPersonHead of Operations
factThe subject's own site
→ Cain McclaryPersonManaging Partner & Founder
factThe subject's own site
→ Blair WillettePersonAssociate
factThe subject's own site
→ Ketan YerneniPersonPrincipal
factThe subject's own site
→ Mack HealyPersonManaging Member
Jan 1, 2020 to presentfactForm ADV, The subject's own site
→ Phil GrayeskiPersonManaging Partner
factThe subject's own site
→ Yusuf UddinPersonHead of Talent
factThe subject's own site
→ Charlee VenablePersonOperations Manager
factThe subject's own site
→ Andrew McclaryPersonManaging Member
Jun 1, 2017 to presentfactForm ADV

Manages (4)

→ KdT Ventures Fund IV, LPFundInferred from name stem
inferenceForm D
→ KDT Ventures Fund II, LPFundVenture Capital Fund
Aug 19, 2022 to presentfactForm ADV
→ KDT Ventures Fund I, LPFundVenture Capital Fund
Aug 19, 2022 to presentfactForm ADV
→ KDT Ventures Fund III, LPFundVenture Capital Fund
Aug 19, 2022 to presentfactForm ADV

Dated events

3 bookkeeping events (roster, classification and holdings changes) folded below

Occurred
Aug 19, 2022
Adviser's first ADV filing
KDT Ventures first filed Form ADV (ERA, venture capital fund adviser exemption)
Form ADVobserved 7 days ago

Show 3 bookkeeping events

Occurred
Aug 19, 2022
KDT Ventures Fund II, LP first reported on Form ADV by KDT Ventures (Venture Capital Fund), GAV $60,000,000
Occurred
Aug 19, 2022
KDT Ventures Fund I, LP first reported on Form ADV by KDT Ventures (Venture Capital Fund), GAV $60,000,000
Occurred
Aug 19, 2022
KDT Ventures Fund III, LP first reported on Form ADV by KDT Ventures (Venture Capital Fund), GAV $80,000,000

Who to call

the organisation, the role and the published line, with the filing or website that published it; revealed to signed-in accounts

The firm's published line

Revealable: 1 business phone (Form ADV), 1 website (Form ADV) · as of 2026-09-12

Also named here, with no published line of their own (reach them through the firm): Kaitlyn Davis (Head of Operations), Cain Mcclary (Managing Partner & Founder), Blair Willette (Associate), Ketan Yerneni (Principal), Mack Healy (Managing Member), Phil Grayeski (Managing Partner), Yusuf Uddin (Head of Talent), Charlee Venable (Operations Manager), Andrew Mcclary (Managing Member).

Who to call is the organisation, the person's role and the line they published themselves: a business phone, office address, website or profile link from Form ADV, Form 13F or their own website, with that source named on every value. The counts above are what a reveal returns; a personal email is rarely published, so most reveals are the firm's line. Never data bought from a provider, never anything personal. Reveals by plan